Abstract-Kallikrein cleaves low molecular weight kininogen to generate vasoactive kinins, which bind to the kinin B2 receptor, triggering a host of biological effects. Kallikrein gene delivery has been shown previously to reduce ischemia/reperfusioninduced cerebral infarction. In this study, we tested the hypothesis that the kinin B2 receptor plays a protective role in ischemic brain injury using kinin B2 receptor gene knockout (B2R-KO) mice subjected to middle cerebral artery occlusion (MCAO). The mortality rate and neurological deficit scores of B2R-KO mice (nϭ48) after MCAO were significantly increased compared with wild-type (WT) mice (nϭ40) when examined over a 14-day period. In addition, the infarct volume in B2R-KO mice was significantly larger than in WT mice at days 1 and 3 after MCAO. Similarly, apoptotic cells, detected by TUNEL labeling counterstained with propidium iodide, and caspase-3 activity in the ischemic brain increased significantly in B2R-KO mice at days 1 and 3 after MCAO. Furthermore, the accumulation of neutrophils in the ischemic brain of B2R-KO mice after MCAO increased when compared with WT mice and was associated with elevated tumor necrosis factor ␣ expression. These alterations in B2R-KO mice correlated with decreased NO levels, Akt, and glycogen synthase kinase-3 phosphorylation and increased nicotinamide-adenine dinucleotide oxidase activity. These results indicate that the kinin B2 receptor promotes survival and protects against brain injury by suppression of apoptosis and inflammation induced by ischemic stroke. The tissue kallikrein-kinin system has been shown previously to exert protective effects in heart after ischemic injury. 6,7 In addition, intracerebroventricular injection of the kallikrein gene has been shown to reduce cerebral infarct size and promote glial cell migration and survival after ischemic stroke. 8 The effects of kallikrein gene delivery were associated with enhanced NO formation, decreased oxidative stress, and activation of cell survival signaling pathways. Our previous studies have shown that the benefits of kallikrein gene delivery in the ischemic heart can be abolished by the administration of a kinin B2 receptor antagonist. 7 Therefore, the kinin B2 receptor may also play an important role in protecting the brain from ischemia/reperfusion (I/R) injury.To determine whether kallikrein/kinin provides neuroprotective effects against ischemic stroke via the kinin B2 receptor, we used wild-type (WT) and kinin B2 receptor knockout (B2R-KO) mice subjected to 90-minute occlusion of the middle cerebral artery followed by reperfusion. We then examined the potential effects of kinin B2 receptor on cell death and inflammatory cell accumulation in the ischemic brain. Our results showed that neurological deficit scores, infarct volume, and mortality rate were significantly elevated in B2R-KO mice in association with increased severity of apoptosis and inflammation in the ischemic brain.
Methods
Animals and TreatmentsMice (male and female, body weight 25 to 30 g), i...